See AcelRx Pharmaceuticals, Inc. (ACRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and No. of Analysts, 4, 4, 4, 4. Average Recommendation: Buy, Average Target Price: 6.50. Number of Ratings: 6, Current Quarters Estimate: -0.19. FY Report Date: 12 / 2019, Current Year's 

NASDAQ | ACRX: Stock News, Ratings & Analysis for Acelrx AcelRx (ACRX) Stock Wins Another Price Target Hike Following Promising News on the Regulatory Front. Investors are jumping in and out ahead of a Food and Drug Administration (FDA) decision on AcelRx Pharmaceuticals, Inc. (ACRX) stock price, quote ... AcelRx Pharmaceuticals (ACRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy). Simply Wall St. AcelRx Pharmaceuticals, Inc. Just Reported, And Analysts Assigned A US$6.40 Price Target Shareholders in AcelRx Pharmaceuticals

$ACRX Stock Technical Analysis | AcelRx | SwingTradeBot.com

Their average twelve-month price target is $6.38, suggesting that the stock has a possible upside of 507.14%. The high price target for ACRX is $10.00 and the  Analyst price targets provided by TipRanks. Quick Links. Advanced Charting · After Hours Quote · Analyst Research  AcelRx Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ACRX updated stock price target summary. See AcelRx Pharmaceuticals, Inc. (ACRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and No. of Analysts, 4, 4, 4, 4. Average Recommendation: Buy, Average Target Price: 6.50. Number of Ratings: 6, Current Quarters Estimate: -0.19. FY Report Date: 12 / 2019, Current Year's  ACRX | Complete AcelRx Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. AcelRx Pharmaceuticals Stock Price Forecast, ACRX stock price prediction. The best long-term & short-term AcelRx Pharmaceuticals share price prognosis for 

See AcelRx Pharmaceuticals, Inc. (ACRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

ACRX Price Target | Acelrx Stock Forecast & Ratings See Acelrx price target based on 3 analysts offering 12 month price targets for Acelrx in the last 3 months. The average price target is $5.33 with a high forecast of $8.00 and a low forecast of $1.00. The average price target represents a 393.52% increase from the last price of $1.08. ACRX Stock Price, Forecast & News (AcelRx Pharmaceuticals) 4 analysts have issued 1 year target prices for AcelRx Pharmaceuticals' stock. Their forecasts range from $2.00 to $10.00. On average, they anticipate AcelRx Pharmaceuticals' stock price to reach $6.38 in the next year. This suggests a possible upside of 507.1% from the stock's current price. View analysts' price targets for AcelRx Pharmaceuticals. ACRX Stock Price | AcelRx Pharmaceuticals Inc. Stock Quote ... ACRX | Complete AcelRx Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Nov 8, 2019 In a report released yesterday, Ladenburg Thalmann & Co. also maintained a Buy rating on the stock with a $10.00 price target. See today's 

ACELRX PHARMACEUTICALS, INC. : Target Price Consensus and ... Mean consensus: BUY: Number of Analysts: 5: Average target price: 5,80 $ Last Close Price: 1,27 $ Spread / Highest target AcelRx Pharmaceuticals (NASDAQ:ACRX) Ratings | Benzinga Jan 01, 2010 · AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and AcelRx Pharmaceuticals Stock Forecast: down to 1.112 USD ...

Here's Why AcelRx Pharmaceuticals (ACRX) Stock Gained Today · By Rachel Aldrich. Sep 15, 2016 4:18 PM EDT. We apologize for any inconvenience.

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. ACRX | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for ACELRX PHARMACEUTICALS INC (ACRX), including profile, stock chart, recent news and events, analyst opinions, and research reports. NASDAQ | ACRX: Stock News, Ratings & Analysis for Acelrx AcelRx (ACRX) Stock Wins Another Price Target Hike Following Promising News on the Regulatory Front. Investors are jumping in and out ahead of a Food and Drug Administration (FDA) decision on AcelRx Pharmaceuticals, Inc. (ACRX) stock price, quote ... AcelRx Pharmaceuticals (ACRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy). Simply Wall St. AcelRx Pharmaceuticals, Inc. Just Reported, And Analysts Assigned A US$6.40 Price Target Shareholders in AcelRx Pharmaceuticals

ACRX: AcelRx Pharmaceuticals, Inc. - Brokerage ... About Brokerage Recommendations Research Earnings Estimates for ACRX Zacks provides the average brokerage recommendation (ABR) for thousands of stocks for most of the leading investment web sties. ACRX -- Is Its Stock Price A Worthy Investment? Learn More. ACRX Stock Summary. The capital turnover (annual revenue relative to shareholder's equity) for ACRX is -0.06 -- better than only 7.15% of US stocks. With a price/sales ratio of 33.37, Acelrx Pharmaceuticals Inc has a higher such ratio than 96.52% of stocks in our set.